Fusion CX IPO
Market Sentiment
IPO Details
Return Estimator (GMP*)
Strengths & Risks
- Healthy grey-market premium — +14% over the issue price.
Our data checks haven't flagged a specific concern for Fusion CX so far — but that isn't a clean bill of health. Read the risk-factors section of the RHP, which lists company-specific risks our data can't capture.
Compiled from this issue's live GMP, subscription, valuation and financial data, and updated as those figures change. Informational only — not investment advice. Always read the RHP before applying.
Resources & Documents
Fusion CX IPO - Quick Take
Fusion CX has fixed the issue price at Rs 289 per share for an issue size of Rs 702 crore. The Mainboard issue is scheduled to open for subscription on October 14, 2026 — 5 days from now.
On our data-signal score, the combined signals for this issue currently read mixed — some indicators read positively and others do not. This is a summary of public data, not a recommendation to apply or skip. All figures below — GMP history, subscription tiers, financials and peers — are aggregated from public disclosures. Always apply through your own broker after reading the RHP.
Frequently Asked Questions
Fusion CX IPO GMP — What It Means
How much weight does a GMP like this carry? Of the 24 Mainboard IPOs we have tracked with a final GMP between 10% and 25%, 22 listed above the issue price, and the typical gap between the GMP-implied and the actual listing gain was 4.7 points. Read it as a guide to direction, not a price target — and alongside subscription demand and the company's fundamentals.
See the full Fusion CX GMP history and trend, or learn how grey market premium works and how reliable it is.
Related IPO
No comments yet. Be the first to share your opinion!